RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+19.74%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.6B
AUM Growth
+$1.6B
(+18%)
Cap. Flow
+$96.8M
Cap. Flow
% of AUM
6.07%
Top 10 Holdings %
Top 10 Hldgs %
27.52%
Holding
150
New
14
Increased
55
Reduced
11
Closed
12
Top Buys
| 1 |
Merck
MRK
|
$36.7M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$15.8M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$14.7M |
| 4 |
Danaher
DHR
|
$12.5M |
| 5 |
PTHN
Patheon N.V.
PTHN
|
$11.9M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$19.8M |
| 2 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
$18M |
| 3 |
Thermo Fisher Scientific
TMO
|
$14.8M |
| 4 |
Pediatrix Medical
MD
|
$9.61M |
| 5 |
XNPT
XENOPORT, INC.
XNPT
|
$8.41M |
Sector Composition
| 1 | Healthcare | 81.88% |
| 2 | Financials | 3.67% |
| 3 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neurocrine Biosciences
NBIX
$13.5B
| $20.8M | 1.3% |
410,000
+500
| +0.1% | +$25.3K |
|
27
Penumbra
PEN
$10.5B
| $20.3M | 1.27% |
266,500
+24,000
| +10% | +$1.82M |
|
28
Prothena Corp
PRTA
$452M
| $18.5M | 1.16% |
308,000
| – | – |
|
29
Biogen
BIIB
$20.8B
| $18.2M | 1.14% |
58,000
+350
| +0.6% | +$110K |
|
30
Pacira BioSciences
PCRX
$1.22B
| $17.2M | 1.08% |
504,000
+31,500
| +7% | +$1.08M |
|
|
AMRN
31
Amarin Corp
AMRN
$311M
| $15.8M | 0.99% |
+4,955,746
| New | +$15.8M |
|
32
Amgen
AMGN
$153B
| $15.7M | 0.98% |
94,000
| – | – |
|
|
WMGI
33
DELISTED
Wright Medical Group Inc
WMGI
| $15M | 0.94% |
613,000
+65,100
| +12% | +$1.6M |
|
34
Incyte
INCY
$17B
| $14.8M | 0.93% |
156,500
+1,500
| +1% | +$141K |
|
|
PRAH
35
DELISTED
PRA Health Sciences, Inc.
PRAH
| $14.3M | 0.9% |
253,000
| – | – |
|
36
McKesson
MCK
$85.9B
| $13.7M | 0.86% |
82,000
+4,100
| +5% | +$684K |
|
37
Galapagos
GLPG
$2.06B
| $13.6M | 0.85% |
210,000
| – | – |
|
38
Bristol-Myers Squibb
BMY
$96.7B
| $13.5M | 0.85% |
250,000
+53,500
| +27% | +$2.88M |
|
39
Jazz Pharmaceuticals
JAZZ
$7.99B
| $13M | 0.81% |
107,000
+5,000
| +5% | +$607K |
|
|
WBA
40
DELISTED
Walgreens Boots Alliance
WBA
| $13M | 0.81% |
161,000
+600
| +0.4% | +$48.4K |
|
|
41
Danaher
DHR
$143B
| $12.5M | 0.79% |
+160,000
| New | +$12.5M |
|
42
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $12.5M | 0.78% |
467,500
+67,500
| +17% | +$1.81M |
|
43
Edwards Lifesciences
EW
$47.7B
| $12.4M | 0.78% |
103,250
+19,750
| +24% | +$2.38M |
|
44
TherapeuticsMD
TXMD
$12.7M
| $12.3M | 0.77% |
1,800,000
+225,000
| +14% | +$1.53M |
|
|
DERM
45
DELISTED
Dermira, Inc.
DERM
| $12M | 0.75% |
355,000
+100
| +0% | +$3.38K |
|
|
PTHN
46
DELISTED
Patheon N.V.
PTHN
| $11.9M | 0.74% |
+400,000
| New | +$11.9M |
|
47
Travere Therapeutics
TVTX
$1.75B
| $11.7M | 0.73% |
522,000
+600
| +0.1% | +$13.4K |
|
48
BioMarin Pharmaceuticals
BMRN
$11.3B
| $11.6M | 0.73% |
125,000
+12,000
| +11% | +$1.11M |
|
49
Encompass Health
EHC
$12.5B
| $10.8M | 0.67% |
265,000
| – | – |
|
|
ACHN
50
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $10.7M | 0.67% |
1,316,000
+3,500
| +0.3% | +$28.4K |
|